MARKET

CDTTW

CDTTW

Conduit Pharmaceuticals
NASDAQ
0.0125
0.0000
0.00%
Closed 09:30 03/20 EDT
OPEN
0.0125
PREV CLOSE
0.0125
HIGH
0.0125
LOW
0.0125
VOLUME
120
TURNOVER
--
52 WEEK HIGH
0.1000
52 WEEK LOW
0.0059
MARKET CAP
--
P/E (TTM)
-0.0732
1D
5D
1M
3M
1Y
5Y
1D
CONDUIT PHARMACEUTICALS PROVIDES RESEARCH AND DEVELOPMENT UPDATE ON PROGRESS FOR PIPELINE ASSETS AZD1656, AZD5658, AND AZD5904
Reuters · 1d ago
CONDUIT PHARMACEUTICALS - RESULTS FOR STUDY WITH CHARLES RIVER LABORATORIES EXPECTED IN Q2 2025
Reuters · 1d ago
Weekly Report: what happened at CDTTW last week (0310-0314)?
Weekly Report · 3d ago
Weekly Report: what happened at CDTTW last week (0303-0307)?
Weekly Report · 03/10 10:22
CONDUIT PHARMACEUTICALS PROVIDES UPDATE ON NASDAQ STOCK MARKET HEARING PANEL
Reuters · 03/06 14:35
Weekly Report: what happened at CDTTW last week (0224-0228)?
Weekly Report · 03/03 10:22
Weekly Report: what happened at CDTTW last week (0217-0221)?
Weekly Report · 02/24 10:22
CONDUIT PHARMACEUTICALS FILES FOR OFFERING OF UP TO $17.8 MLN OF SHARES OF COMMON STOCK - SEC FILING
Reuters · 02/19 14:06
More
About CDTTW
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto’s Thyroiditis (HT and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).

Webull offers Conduit Pharmaceuticals Inc stock information, including NASDAQ: CDTTW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTTW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTTW stock methods without spending real money on the virtual paper trading platform.